₹4.11 for Q4 which decreased by 52.78% Y-o-Y. Tatva Chintan Pharma Chem has delivered -1.97% return in the last 1 week, -14.66% return in last 6 months and -23.33% YTD return.
Currently the Tatva Chintan Pharma Chem has a market cap of ₹2872.89 Cr and 52wk high/low of ₹1887.95 & ₹1061.35 respectively. As of 05 May, 2024 out of 5 analysts covering the company, 1 analyst has given Sell rating, 1 analyst has given Hold rating, 1 analyst has given Buy rating &2 analysts have given Strong Buy rating.
Read more on livemint.com